Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. (Q52545012)

3 May 2018

title

Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. (English)

1 reference

3 May 2018

author name string

Stephen W Tobin

1

1 reference

3 May 2018

Karen Douville

2

1 reference

3 May 2018

Ulrike Benbow

3

1 reference

3 May 2018

Constance E Brinckerhoff

4

1 reference

3 May 2018

Vincent A Memoli

5

1 reference

3 May 2018

Bradley A Arrick

6

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

3 May 2018

published in

Oncogene

1 reference

3 May 2018

volume

21

1 reference

3 May 2018

issue

1

1 reference

3 May 2018

page(s)

108-118

1 reference

3 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205026

exact match

0 references

cites work

An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Overexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor-beta in breast cancer: a working hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Reversible inhibition of mammary gland growth by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Autocrine transforming growth factor beta 1 modulates the expression of integrin alpha 5 beta 1 in human colon carcinoma FET cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205026

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205026

1 reference

3 May 2018

PubMed ID

11791181

1 reference

3 May 2018